Indian Wafer Fab Will be Specialty Foundry
Peter Clarke, EETimes
7/10/2015 01:58 PM EDT
LONDON — Cricket Semiconductor—a company set up with the purpose of building and operating $1 billion analog and power semiconductor wafer fab in India—will operate as a specialty foundry, according to Lou Hutter, one of two former Texas Instruments executives who formed the company.
Cricket Semiconductor's plan is to break ground in 2016 on the wafer fab and to begin producing chips for customers in 2018, Hutter said in email correspondence to EE Times Europe. And Cricket has plans for additional fabs in the future although the company is focused right now on getting its first wafer fab constructed.
|
|
E-mail This Article |
|
Printer-Friendly Page |
Related News
- SkyWater to Acquire Infineon's Austin Fab and Establish Strategic Partnership to Expand U.S. Foundry Capacity for Foundational Chips
- Intel considers foundry split, fab cancellations
- Urgent Orders Boost Wafer Foundry Utilization in Q2; Global Top 10 Foundry Revenue Grows 9.6% while VIS Climbs Two Spots, Says TrendForce
- PsiQuantum Expands Development Engagement and Plan for Production Ramp of Quantum Computing Technology at SkyWater's Minnesota Fab
- Foundry Revenue Is Forecasted to Drop by 4% YoY for 2023 Due to Slow Inventory Consumption and Falling Wafer Input from Customers, Says TrendForce
Breaking News
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- RISC-V Royalty-Driven Revenue to Exceed License Revenue by 2027
- Keysom Unveils Keysom Core Explorer V1.0
Most Popular
- RISC-V International Promotes Andrea Gallo to CEO
- See the 2025 Best Edge AI Processor IP at the Embedded Vision Summit
- Andes Technology Showcases RISC-V AI Leadership at RISC-V Summit Europe 2025
- Ceva, Inc. Announces First Quarter 2025 Financial Results
- Cadence Unveils Millennium M2000 Supercomputer with NVIDIA Blackwell Systems to Transform AI-Driven Silicon, Systems and Drug Design






